Medically reviewed by a licensed healthcare professional. Last updated April 2026.
What the Review Data Shows
Zepbound (tirzepatide) has accumulated thousands of patient reviews since its launch in November 2023. We analyzed feedback from multiple sources to give you an honest picture of what real patients experience.
- Zepbound has strong patient satisfaction ratings across major review platforms
- Most patients report noticeable appetite reduction within the first 2 weeks
- GI side effects (nausea, constipation) are the most common complaints, especially during dose escalation
- Weight loss results vary widely: some patients lose 20%+ of body weight, others see more modest results
Overall sentiment: Strongly positive. Zepbound consistently earns higher satisfaction ratings than most other weight loss medications. Patients who stay on it long enough to reach therapeutic doses (5mg and above) report the highest satisfaction.
Weight Loss Results Patients Report
The most talked-about aspect of Zepbound reviews is, naturally, how much weight people lose. Clinical trials showed an average of 20.9% body weight loss at the 15mg dose, but individual experiences vary significantly.
What patients commonly report:
- First month (2.5mg): 3-8 pounds lost. Most of this is water weight and reduced food intake. Some patients see more, others see less. This is the dose escalation phase, not the therapeutic phase.
- Months 2-3 (5mg): Weight loss accelerates. Many patients report losing 1-2 pounds per week consistently. Appetite suppression becomes more noticeable.
- Months 4-6 (7.5-10mg): This is where the most dramatic results tend to occur. Patients frequently report 15-30 pounds lost by this point.
- Months 6-12 (10-15mg): Continued steady loss, though the rate typically slows. Many patients reach 15-20% body weight loss in this window.
Important context: The patients who post reviews online skew toward both extremes. You are more likely to see posts from people with dramatic results or people with severe side effects. The average experience is somewhere in between.
Side Effects: What Patients Actually Experience
Side effects are the second most discussed topic in Zepbound reviews. The pattern is consistent: GI symptoms dominate, they are worst during the first 2-4 weeks of each dose increase, and they generally improve over time.
Most Commonly Reported Side Effects
| Side Effect | How Often Mentioned | Typical Duration |
|---|---|---|
| Nausea | Very common | 1-3 weeks after each dose increase |
| Constipation | Common | Ongoing for some; manageable with fiber |
| Reduced appetite (beyond desired) | Common | Usually stabilizes after 4-6 weeks |
| Fatigue | Moderate | First 2 weeks of new dose |
| Diarrhea | Moderate | Intermittent, usually early on |
| Injection site reactions | Less common | Minor redness that fades quickly |
| Sulfur burps | Less common but frequently mentioned | Varies; dietary changes can help |
What Patients Say Helps
Patient forums and reviews frequently recommend these strategies for managing side effects:
- Eating smaller, more frequent meals rather than trying to eat full-sized portions
- Staying hydrated (many patients report dehydration worsens nausea)
- Ginger tea or ginger chews for nausea management
- Fiber supplements or stool softeners for constipation
- Injecting in the evening so you sleep through the worst of any nausea
- Avoiding fatty or greasy foods during the first week after a dose increase
Cost: The Biggest Complaint
If there is one universal frustration in Zepbound reviews, it is the cost. Patients who pay retail ($1,060+/month) express far more dissatisfaction than those using savings programs.
Common cost-related feedback:
- Patients using Lilly's savings card ($25/month with commercial insurance) give the highest overall satisfaction ratings
- The uninsured savings card (~$499/month) gets mixed reviews; better than retail but still a significant monthly expense
- Insurance denials and prior authorization hurdles generate the most negative feedback
- Many patients report switching to compounded tirzepatide when insurance stops covering it or copay accumulator programs kick in
Read our cheapest tirzepatide guide for every way to lower your Zepbound costs.
Zepbound vs. Wegovy: What Patients Who Tried Both Say
A subset of reviewers have tried both Zepbound and Wegovy, giving us valuable comparison data.
Common comparisons:
- Weight loss: Most patients who tried both report better results on Zepbound, consistent with clinical trial data showing tirzepatide outperforming semaglutide
- Side effects: Mixed. Some patients tolerate one better than the other. There is no consistent pattern, suggesting individual variation matters more than the medication itself
- Appetite suppression: Described as "stronger" and "more consistent" on Zepbound by many patients, though some prefer semaglutide's appetite effects
- Cost: Similar retail pricing, but savings program details differ. Some patients have insurance coverage for one but not the other
See our full Wegovy vs. Zepbound comparison for a detailed breakdown.
Who Should Consider Zepbound
Based on patient reviews and clinical data, Zepbound tends to work best for:
- Patients with BMI 30+ (or 27+ with weight-related conditions) who need significant weight loss
- Patients who tried semaglutide with underwhelming results
- Patients willing to commit to 6+ months of treatment for full effect
- Patients who can access insurance coverage or afford the medication long-term
Who Might Want to Look Elsewhere
- Patients who are extremely sensitive to GI side effects (tirzepatide's dual mechanism can cause stronger GI symptoms)
- Patients who need Medicare or Medicaid coverage (not currently covered for weight loss)
- Patients looking for a short-term solution (stopping the medication often leads to weight regain)
The Bottom Line
Zepbound has earned strong patient reviews for good reason. It is the most effective weight loss medication available, and most patients who can access it and tolerate the side effects report life-changing results. The biggest barriers remain cost and insurance coverage, not the medication itself.
If you are considering Zepbound, take our provider quiz to find the right prescriber, or compare all telehealth providers that offer tirzepatide programs.
Compounded GLP-1 medications are not FDA-approved. While legal during FDA-recognized drug shortages, they do not undergo the same rigorous testing as brand-name drugs. Always verify your provider uses a licensed 503A or 503B compounding pharmacy.
Sources
- SURMOUNT-1 Trial, NEJM 2022
- SURMOUNT-5 Head-to-Head Trial, 2024
- Zepbound Prescribing Information, FDA
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Individual results vary. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you are experiencing a medical emergency, call 911.